Las Vegas, Nevada - The recent conclusion of the third bellweather legal case against Takeda Pharmaceuticals Inc., makers of Actos, resulted in a victory for the defendent, clearing Takeda of any liability. Prompted by the finding, LawsuitLegal.com is offering a no obligation initial consultation for people who suffered bladder cancer and allege Actos may be responsible, and who would like to learn more about their options following the decision.
The jury in the case was informed of the plaintiff having developed terminal bladder cancer following taking Actos to treat type 2 diabetes. The jury found that smoking and other contributing factors may also have led to the plaintiffs condition and led to the link between Actos and bladder cancer not being definitively confirmed.
"With over 2,750 lawsuits in the Actos multidistrict litigation*, the findings of this case leave a lot of unanswered questions from those who have filed a claim, and those who have yet to come forward," added a spokesperson for the company when asked about the landmark case (* Actos Product Liability Litigation, MDL No. 2299).
According to the company, the MDL will continue its way through the court system, with juries hearing arguments from attorneys from both sides of the case. The legal review offer being extended is an opportunity for people to speak to a lawyer and find out what all that has happened means for them.
To be eligible for the special offer and receive a no obligation legal review, applicants must have a confirmed diagnosis of bladder cancer and have a history of taking the diabetes medication Actos. Eligible parties who would like more information should contact the company to request a legal review immediately.